Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 23 | -137 | -46 | 483 |
| Net Acquisitions | N/A | N/A | 162 | N/A | 107 |
| Purchase Sale Intangibles | N/A | N/A | -57 | -14 | N/A |
| Investing Cash Flow | $-1 | $23 | $-32 | $-60 | $590 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 550 | N/A | 3,373 | N/A | N/A |
| Common Stock Issued | 2,903 | 9,772 | 7 | 21,480 | 2,152 |
| Common Stock Repurchased | -121 | -695 | -45 | -1,776 | N/A |
| Other Financing Activity | 99 | -13 | -5 | 0 | 0 |
| Financing Cash Flow | $3,431 | $9,063 | $3,330 | $19,704 | $2,152 |
| Exchange Rate Effect | -28 | 229 | -3 | 103 | -40 |
| Beginning Cash Position | 1,311 | 1,080 | 9,344 | 320 | 1,292 |
| End Cash Position | 3,426 | 1,354 | 1,137 | 11,675 | 317 |
| Net Cash Flow | $2,143 | $45 | $-8,204 | $11,252 | $-936 |
| Free Cash Flow | |||||
| Capital Expenditure | -5 | -23 | -194 | -60 | -18 |
| Free Cash Flow | -5 | -23 | -194 | -60 | -18 |